comparemela.com
Home
Live Updates
Starlight Therapeutics, a Subsidiary of Lantern Pharma Focus
Starlight Therapeutics, a Subsidiary of Lantern Pharma Focus
Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS and Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer
DALLAS - Starlight Therapeutics a Lantern Pharma subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective...
Related Keywords
San Francisco ,
California ,
United States ,
Dallas ,
Texas ,
Pionyr Immunotherapeutics ,
Los Angeles ,
Marc Chamberlain ,
Exchange Commission ,
University Of South Florida ,
Securities Exchange ,
Starlight Therapeutics Inc ,
Columbia University College Of Physicians ,
Moores Cancer Center ,
Norris Cancer Center ,
Fred Hutchinson Cancer Center ,
University Of California ,
University Of Washington ,
Moffit Cancer Center ,
Chief Medical ,
Cancer Center ,
South Florida ,
Hutchinson Cancer Center ,
Starlight Therapeutics ,
University College ,
Therapeutics Inc ,
Securities Act ,
Securities Exchange Act ,
Risk Factors ,
Annual Report ,
News Publishing ,
Markets ,